Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for XTLB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
December 31, 2024 8.55M
September 30, 2024 9.28M
June 30, 2024 2.398M
March 31, 2024 2.928M
December 31, 2023 2.426M
September 30, 2023 2.663M
June 30, 2023 2.881M
March 31, 2023 3.322M
December 31, 2022 4.186M
September 30, 2022 4.897M
June 30, 2022 5.757M
March 31, 2022 6.621M
December 31, 2021 6.618M
September 30, 2021 6.855M
June 30, 2021 6.953M
March 31, 2021 7.311M
December 31, 2020 6.503M
September 30, 2020 6.21M
June 30, 2020 6.789M
March 31, 2020 7.269M
December 31, 2019 7.212M
September 30, 2019 8.289M
June 30, 2019 9.548M
March 31, 2019 12.43M
December 31, 2018 8.575M
Date Value
September 30, 2018 7.469M
June 30, 2018 6.436M
March 31, 2018 6.429M
December 31, 2017 6.586M
September 30, 2017 6.825M
June 30, 2017 7.172M
March 31, 2017 7.796M
December 31, 2016 3.017M
September 30, 2016 4.056M
June 30, 2016 4.337M
March 31, 2016 4.758M
December 31, 2015 5.323M
September 30, 2015 7.485M
June 30, 2015 7.861M
March 31, 2015 5.013M
December 31, 2014 5.644M
September 30, 2014 6.688M
June 30, 2014 7.224M
March 31, 2014 7.743M
December 31, 2013 8.015M
September 30, 2013 10.28M
June 30, 2013 9.38M
March 31, 2013 10.42M
December 31, 2012 11.09M
September 30, 2012 10.60M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
BioLineRx Ltd. 38.80M
Kamada Ltd. 383.16M
Can-Fite BioPharma Ltd. --
Galmed Pharmaceuticals Ltd. 16.03M
Revium Recovery, Inc. 18.79M